2017
DOI: 10.1136/emermed-2016-206129
|View full text |Cite
|
Sign up to set email alerts
|

Remifentanil for procedural sedation: a systematic review of the literature

Abstract: There is currently a lack of high-quality data on the use of remifentanil in the ED. Physicians should exert caution when using remifentanil in the absence of published standardised dosing protocols in light of frequently reported paediatric respiratory depression. However, PSA efficacy combined with faster recovery times merit ongoing investigations into its use.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

2
12
0
1

Year Published

2019
2019
2023
2023

Publication Types

Select...
6
3

Relationship

0
9

Authors

Journals

citations
Cited by 19 publications
(15 citation statements)
references
References 24 publications
2
12
0
1
Order By: Relevance
“…However, the propofol/fentanyl group showed a lower success rate in muscle relaxation and a higher rate of apnea (55). These findings were confirmed by similar studies (81)(82)(83). In the study by Kasmaee et al, agitation and apnea were observed in 25% and 9.4% of the patients in the propofol/fentanyl group, respectively; the frequency of apnea was 32% in the remifentanil group (55).…”
Section: Propofol/fentanyl Versus Remifentanilsupporting
confidence: 67%
“…However, the propofol/fentanyl group showed a lower success rate in muscle relaxation and a higher rate of apnea (55). These findings were confirmed by similar studies (81)(82)(83). In the study by Kasmaee et al, agitation and apnea were observed in 25% and 9.4% of the patients in the propofol/fentanyl group, respectively; the frequency of apnea was 32% in the remifentanil group (55).…”
Section: Propofol/fentanyl Versus Remifentanilsupporting
confidence: 67%
“…In the current study, the low incidence of nausea, vomiting, and chest congestion in patients administered remifentanil was due to its inhibitory effects on carboprost-induced smooth muscle contraction (Holzer, 2009) as well as its sedation effects (Kisilewicz et al, 2017). In the clinic, we observed that the remifentanil's antiemetic benefit was better than usual antiemetics given at the time of carboprost because the rapid onset of remifentanil and latency effect of usual antiemetics.…”
Section: Discussionmentioning
confidence: 47%
“…In parturient patients treated with remifentanil, the need for rescue analgesia (with sufentanil) and the maximal VAS scores were both reduced. The sedation and analgesic effects of remifentanil (Kisilewicz et al, 2017) and the reduced incidence of carboprost side effects contributed to improved comfort and satisfaction of the mothers in group R compared with those in group C. Furthermore, the mean minimum RRs and the mean minimum SpO 2 were both within normal ranges. Studies have shown that remifentanil can be safely used during labor analgesia, with few side effects on the fetus (Ohashi et al, 2016;Wilson et al, 2018).…”
Section: Discussionmentioning
confidence: 88%
“…In clinical general anesthesia, propofol combined with remifentanil is mainly used for drug compatibility, which has the advantages of rapid anesthesia and postoperative recovery ( 15 , 16 ). Propofol ( 17 ) can be rapidly removed from the central ventricle through liver metabolism and renal excretion, while remifentanil ( 18 , 19 ) can be rapidly degraded by non-specific esterase, which was advantageous in rapid action, short action time, rapid removal without accumulation during continuous infusion. Inhalation anesthesia also has advantages including quick effect and discharge, little influence on circulation and respiration, and non-invasive administration.…”
Section: Discussionmentioning
confidence: 99%